Zacks.com Announces That Vivian Lewis Highlights the Following Stocks: Teva, ICICI Bank Ltd and Sanofi.CHICAGO -- Vivian Lewis provides information on global investing and the effects of international politics on stocks and bonds. Benefit from this expert's commentary and analysis, and read about Teva (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on :TEVA), ICICI Bank Ltd (NYSE NYSE See: New York Stock Exchange :IBN IBN Internet Business Network IBN Institute of Bioengineering and Nanotechnology IBN Institut Belge de Normalisation IBN Islamic Broadcasting Network IBN Integrated Business Network IBN Identification Beacon IBN Isolated Bonding Network ) and Sanofi (NYSE:SNY). Vivian Lewis is the editor of the Global Investing newsletter. Click here for the full story exclusively on Zacks.com: http://at.zacks.com/?id=84 Highlights from the April 4th Featured Expert column by Vivian Lewis include: Buy and Hold... Teva (NASDAQ:TEVA) got tentative FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. approval for Topiramate capsules, the generic equivalent of Ortho-McNeil's Topamax to treat migraine and cluster headache, epilepsy, and weight loss. Teva won 3 more FDA ok's, for olanzapine, the generic of Eli Lilly's Zyprexa psychotropic treatment for schizophrenia and acute manic episodes, with a $4.8 bn/yr market; for amlodipine besylate, the generic of Pfizer's Novarsc for hypertension and forms of angina, with a $2.6 bn/yr market; and for octreotidin acetate, generic of Novartis' sandrostaten (TM) worth $80 mn/yr. All depend on various legal actions before they kick in. ICICI Bank Ltd (NYSE:IBN) and Britain's Prudential plc are restructuring the shareholding in their Indian jv, Prudential ICICI ICICI Industrial Credit and Investment Corporation of India Asset Management. ICICI agreed to purchase from Pru an additional 6% share of Prudential ICICI and its trustee, bringing ICICI to 51% with Pru at 49%, subject to a raft of approvals. IBN's U.S. GAAP GAAP See: Generally Accepted Accounting Principles GAAP See generally accepted accounting principles (GAAP). 9-mo net income hit Rs. 525 crore n. 1. Ten millions; as, a crore of rupees (which is nearly $5,000,000) s>. Noun 1. crore - the number that is represented as a one followed by 7 zeros; ten million ($121 mn) for 2004-5 vs net income of Rs. 232 crore ($54 mn) for Apr.-Dec. 2003. Sanofi (NYSE:SNY) (via its vaccine sub, Pasteur) says the FDA's Vaccines and Related Biological Products Advisory Committee unanimously recommended licensing Adacel(TM) (Tetanus Toxoid and Reduced Diphtheria Toxoid toxoid, protein toxin treated by heat or chemicals so that its poisonous property is destroyed but its capacity to stimulate the formation of toxin antibodies, or antitoxins, remains. and Acellular Pertussis Vaccine acellular pertussis vaccine n. Abbr. DTaP A diphtheria, tetanus, pertussis vaccine containing two or more antigens but no whole cells. Adsorbed) Vaccine as a booster for people aged 11-64. For the 2005- 06 flu season, Sanofi will offer a new formulation of pediatric pediatric /pe·di·at·ric/ (pe?de-at´rik) pertaining to the health of children. pe·di·at·ric adj. Of or relating to pediatrics. influenza vaccine that contains no preservatives at all. The FDA approved the new formulation of its pediatric influenza vaccine for in children 6-35 mos. Read Vivian Lewis' market commentary, receive more information on the stocks above and take a look at all of the positions in her portfolios by clicking: http://at.zacks.com/?id=85 About Zacks Featured Experts Successful investing requires professional advice from knowledgeable experts who can help investors achieve their financial goals in good markets and improve their portfolios, especially in bad ones. That is why Zacks Investment Research Zacks Investment Research A firm that compiles earnings estimates and brokerage firm investment recommendations for thousands of publicly traded firms. has assembled the best investment experts in the business to offer their powerful advisory newsletters on all the major investment topics: Stocks, Mutual Funds, Bonds, Options, Futures etc. Additional recommendations from Zacks.com Featured Experts are highlighted in the free investment newsletter, Profit from the Pros. Each issue highlights several Featured Experts in this free e-mail newsletter. Register for a free subscription to "Profit from the Pros" at: http://at.zacks.com/?id=86 About Zacks Zacks.com is a property of Zacks Investment Research, Inc., which was formed in 1978 to compile, analyze, and distribute investment research to both institutional and individual investors. The guiding principle behind Zacks work is the belief that investment experts, such as brokerage analysts and investment newsletter writers, have superior knowledge about how to invest successfully. The goal is to unlock these pros' profitable insights for individual investors hard-pressed to find this valuable information in one source. A free subscription to "Profit from the Pros" weekly e-mail newsletter provides the best way to use these experts' insights for more profitable investing. Register now for a free subscription to the Profit from the Pros newsletter at http://at.zacks.com/?id=87 Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates. Disclaimer: Past performance does not guarantee future results. Investors should always research companies and securities before making any investments. Nothing herein should be construed as an offer or solicitation to buy or sell any security. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion